Table 3:
Variable | Patients who reported no change or improved seizure control (146) |
Patients who reported worsened seizure control (31) |
p-value |
---|---|---|---|
Age – median (years) | 48 (IQR 25) | 44 (IQR 11) | 0.231 |
Gender – female | 67.1% (98) | 66.7% (22) | 0.840 |
Race / Ethnicity | 0.542 | ||
13.4% Not answered (20) | 6.5% Not answered (2) | ||
Duration of epilepsy in years (median) | 16 (IQR 26) | 12 (IQR 9) | 0.062 |
Unknown | 10.3% (15) | 6.5% (2) | |
Intractable Epilepsy | 44.5% (65) | 61.3% (19) | 0.089 |
Number of anti-seizure medications (median) | 1 (IQR 1) | 2 (IQR 1) | 0.178 |
Mar, Apr, May 2020 | 0 (IQR 0, range 0–7.5) | 2 (IQR 6, range 0 - ≥10) | <0.001 |
9.6% (14) | 12.9% (4) | 0.829 | |
control during acute infection | |||
I have no clear triggers | 37.7% (55) | 22.6% (7) | 0.110 |
Believe fear of getting COVID-19 worsened seizures | 5.5% (8) | 61.3% (19) | <0.001 |
Increased / worsened stress due to the COVID-19 pandemic | 50% (73) | 80.6% (25) | 0.002 |
Worse sleep due to the COVID-19 pandemic | 41.8% (61) | 48.4% (15) | 0.275 |
Worse epilepsy care during the COVID-19 pandemic | 12.3% (18) | 38.7% (12) | <0.001 |
Difficulty obtaining anti-seizure medications | 7.5% (11) | 19.4% (6) | 0.042 |
Patient canceled a Neurology appointment | 20.5% (30) | 9.7% (3) | 0.369 |
Neurologist canceled an appointment | 26% (38) | 35.5% (11) | 0.528 |
Effective way to get epilepsy care: Yes | 75% (24/32) | 50% (4/8) | 0.243 |
Effective way to get epilepsy care: Yes | 77.3% (68/88) | 66.7% (12/18) | 0.626 |